Hong Kong Pharma Digital Technology Holdings Limited(HKPD)Earnings, Financials & Key Ratios
HKPD•NASDAQ
$0.65
$7M mkt cap·Price updated May 6, 2026
SectorIndustrialsIndustryFreight & LogisticsSub-IndustryContract Logistics and Specialized Warehousing
AboutHong Kong Pharma Digital Technology Holdings Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. It focuses on cross-border pharmaceutical warehousing, cross-border OTC registration and import, and OTC product wholesale services. The company was founded by Lap Sun Wong on August 17, 2023 and is headquartered in Hong Kong.Show more
- Revenue$20M+21.7%
- EBITDA$1M-52.4%
- Net Income-$27K-102.0%
- EPS (Diluted)-0.00-101.7%
- Gross Margin11.89%-44.2%
- EBITDA Margin5.93%-60.9%
- Operating Margin0.65%-93.3%
- Net Margin-0.13%-101.7%
- ROE-0.59%-101.1%
- ROIC1.61%-95.7%
- Debt/Equity0.48-3.0%
- Interest Coverage1.35-93.0%
HKPD Key Insights
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 75.0%
- ✓Trading at only 1.3x book value
- ✓Efficient asset utilization: 2.2x turnover
✗Weaknesses
- ✗Shares diluted 38.6% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
HKPD Price & Volume
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) stock price & volume — 10-year historical chart
Loading chart...
HKPD Growth Metrics
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years58.24%
5 Years58.24%
3 Years58.24%
Last Year2.2%
HKPD Peer Comparison
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) competitors in Contract Logistics and Specialized Warehousing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ATXG | 2.78M | 4.81 | -0.38 | -18.88% | -201.97% | -31.72% | 1.03 | |
 CNET | 1.99M | 0.75 | -0.40 | -49.52% | -33.36% | -60.34% | 0.03 | |
 BTBT | 621.7M | 1.93 | 9.65 | 264.59% | 21.41% | 0.03 | ||
 HCWB | 13.6M | 0.35 | -0.46 | -9.68% | -28.56% | -8.97% | ||
 NUVB | 1.75B | 5.04 | -8.40 | 6.99% | -102.06% | -44.1% | 0.03 | |
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 | |
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 OPRX | 120.61M | 6.47 | 23.96 | 18.78% | 4.69% | 4.22% | 0.04 |
Compare HKPD vs Peers
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HKPD Income Statement
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Sales/Revenue | 12.56M | 16.69M | 20.31M |
| Revenue Growth % | - | 32.91% | 21.72% |
| Cost of Goods Sold | 9.82M | 13.13M | 17.9M |
| COGS % of Revenue | 78.19% | 78.68% | 88.11% |
| Gross Profit | 2.74M▲ 0% | 3.56M▲ 29.9% | 2.42M▼ 32.1% |
| Gross Margin % | 21.81% | 21.32% | 11.89% |
| Gross Profit Growth % | - | 29.93% | -32.13% |
| Operating Expenses | 1.7M | 1.95M | 2.28M |
| OpEx % of Revenue | 13.5% | 11.69% | 11.24% |
| Selling, General & Admin | 1.76M | 1.89M | 2.22M |
| SG&A % of Revenue | 14% | 11.32% | 10.91% |
| Research & Development | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | -62.95K | 60.95K | 67.26K |
| Operating Income | 1.04M▲ 0% | 1.61M▲ 54.1% | 132.04K▼ 91.8% |
| Operating Margin % | 8.31% | 9.64% | 0.65% |
| Operating Income Growth % | - | 54.08% | -91.79% |
| EBITDA | 1.76M | 2.53M | 1.21M |
| EBITDA Margin % | 14% | 15.18% | 5.93% |
| EBITDA Growth % | - | 44.1% | -52.43% |
| D&A (Non-Cash Add-back) | 714.59K | 925.58K | 1.07M |
| EBIT | 1.04M | 1.61M | 133.78K |
| Net Interest Income | -23.02K | -82.29K | -95.93K |
| Interest Income | 219 | 474 | 1.74K |
| Interest Expense | 23.24K | 82.77K | 97.67K |
| Other Income/Expense | -23.02K | -82.29K | -95.93K |
| Pretax Income | 1.02M▲ 0% | 1.53M▲ 49.5% | 36.11K▼ 97.6% |
| Pretax Margin % | 8.13% | 9.14% | 0.18% |
| Income Tax | 22.57K | 196.25K | 63.17K |
| Effective Tax Rate % | 2.21% | 12.86% | 174.92% |
| Net Income | 998.2K▲ 0% | 1.33M▲ 33.2% | -27.06K▼ 102.0% |
| Net Margin % | 7.95% | 7.97% | -0.13% |
| Net Income Growth % | - | 33.21% | -102.03% |
| Net Income (Continuing) | 998.2K | 1.33M | -27.06K |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | 0.09▲ 0% | 0.18▲ 98.5% | -0.00▼ 101.7% |
| EPS Growth % | - | 98.46% | -101.67% |
| EPS (Basic) | 0.09 | 0.18 | -0.00 |
| Diluted Shares Outstanding | 11M | 7.37M | 10.21M |
| Basic Shares Outstanding | 11M | 7.37M | 9.02M |
| Dividend Payout Ratio | - | - | - |
HKPD Balance Sheet
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) balance sheet — assets, liabilities & shareholders' equity
| Line item | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Total Current Assets | 2.75M | 7.8M | 8.73M |
| Cash & Short-Term Investments | 524.61K | 619.58K | 3.01M |
| Cash Only | 524.61K | 619.58K | 748.72K |
| Short-Term Investments | 0 | 0 | 2.26M |
| Accounts Receivable | 1.7M | 3.72M | 4.71M |
| Days Sales Outstanding | 49.35 | 81.33 | 84.69 |
| Inventory | 190.89K | 933.3K | 559.98K |
| Days Inventory Outstanding | 7.1 | 25.95 | 11.42 |
| Other Current Assets | 268.98K | 1.27M | 400 |
| Total Non-Current Assets | 658.29K | 865.52K | 690.17K |
| Property, Plant & Equipment | 654.26K | 833.69K | 593.73K |
| Fixed Asset Turnover | 19.19x | 20.02x | 34.21x |
| Goodwill | 0 | 0 | 0 |
| Intangible Assets | 4.03K | 31.82K | 96.44K |
| Long-Term Investments | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 |
| Total Assets | 3.41M▲ 0% | 8.67M▲ 154.4% | 9.42M▲ 8.7% |
| Asset Turnover | 3.69x | 1.93x | 2.16x |
| Asset Growth % | - | 154.41% | 8.65% |
| Total Current Liabilities | 2.55M | 3.18M | 2.92M |
| Accounts Payable | 1.4M | 1.32M | 1.73M |
| Days Payables Outstanding | 52.08 | 36.78 | 35.23 |
| Short-Term Debt | 62.35K | 215.2K | 371.56K |
| Deferred Revenue (Current) | 268.03K | 191.07K | 124.51K |
| Other Current Liabilities | 0 | 0 | 0 |
| Current Ratio | 1.08x | 2.46x | 2.99x |
| Quick Ratio | 1.00x | 2.16x | 2.80x |
| Cash Conversion Cycle | 4.38 | 70.5 | 60.87 |
| Total Non-Current Liabilities | 271.45K | 1.24M | 1.51M |
| Long-Term Debt | 116.86K | 1.12M | 1.5M |
| Capital Lease Obligations | 154.59K | 117.84K | 6.41K |
| Deferred Tax Liabilities | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 |
| Total Liabilities | 2.82M | 4.41M | 4.43M |
| Total Debt | 691.08K | 2.09M | 2.37M |
| Net Debt | 166.46K | 1.47M | 1.63M |
| Debt / Equity | 1.18x | 0.49x | 0.48x |
| Debt / EBITDA | 0.39x | 0.82x | 1.97x |
| Net Debt / EBITDA | 0.09x | 0.58x | 1.35x |
| Interest Coverage | 44.91x | 19.43x | 1.35x |
| Total Equity | 585.24K▲ 0% | 4.25M▲ 626.8% | 4.99M▲ 17.3% |
| Equity Growth % | - | 626.82% | 17.31% |
| Book Value per Share | 0.05 | 0.58 | 0.49 |
| Total Shareholders' Equity | 585.24K | 4.25M | 4.99M |
| Common Stock | 6.84K | 10K | 11K |
| Retained Earnings | 201.39K | 1.53M | 1.5M |
| Treasury Stock | 0 | 0 | 0 |
| Accumulated OCI | -4.34K | -4.86K | 10.82K |
| Minority Interest | 0 | 0 | 0 |
HKPD Cash Flow Statement
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) cash flow — operating, investing & free cash flow history
| Line item | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|
| Cash from Operations | 1.73M | -394.33K | 569.21K |
| Operating CF Margin % | 13.76% | -2.36% | 2.8% |
| Operating CF Growth % | - | -122.83% | 244.35% |
| Net Income | 998.2K | 1.33M | -27.06K |
| Depreciation & Amortization | 714.59K | 925.58K | 1.07M |
| Stock-Based Compensation | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | -708 | 43.15K |
| Working Capital Changes | 14.3K | -2.65M | -520.25K |
| Change in Receivables | -929.51K | -2.09M | -1.02M |
| Change in Inventory | -191.16K | -741.95K | 378.2K |
| Change in Payables | 955.27K | -105.22K | 396.88K |
| Cash from Investing | -132.09K | -40.8K | -2.45M |
| Capital Expenditures | -114.64K | -52.74K | -69.92K |
| CapEx % of Revenue | 0.91% | 0.32% | 0.34% |
| Acquisitions | 0 | 0 | 0 |
| Investments | - | - | - |
| Other Investing | -17.45K | 11.94K | -85.07K |
| Cash from Financing | -1.16M | 537.32K | 2M |
| Debt Issued (Net) | -1.16M | 373.03K | -927.31K |
| Equity Issued (Net) | 0 | 509.5K | 1000K |
| Dividends Paid | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 |
| Other Financing | 0 | -345.22K | -1.38M |
| Net Change in Cash | 439.63K▲ 0% | 102.64K▼ 76.7% | 121.86K▲ 18.7% |
| Free Cash Flow | 1.61M▲ 0% | -482.35K▼ 130.0% | 414.23K▲ 185.9% |
| FCF Margin % | 12.82% | -2.89% | 2.04% |
| FCF Growth % | - | -129.97% | 185.88% |
| FCF per Share | 0.15 | -0.07 | 0.04 |
| FCF Conversion (FCF/Net Income) | 1.73x | -0.30x | -21.04x |
| Interest Paid | 7.31K | 82.77K | 97.67K |
| Taxes Paid | 0 | 0 | 294.83K |
HKPD Key Ratios
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Return on Equity (ROE) | 170.56% | 54.96% | -0.59% |
| Return on Invested Capital (ROIC) | 104.14% | 37.27% | 1.61% |
| Gross Margin | 21.81% | 21.32% | 11.89% |
| Net Margin | 7.95% | 7.97% | -0.13% |
| Debt / Equity | 1.18x | 0.49x | 0.48x |
| Interest Coverage | 44.91x | 19.43x | 1.35x |
| FCF Conversion | 1.73x | -0.30x | -21.04x |
| Revenue Growth | - | 32.91% | 21.72% |
HKPD Frequently Asked Questions
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) reported $20.3M in revenue for fiscal year 2025. This represents a 62% increase from $12.6M in 2023.
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) grew revenue by 21.7% over the past year. This is strong growth.
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) reported a net loss of $0.0M for fiscal year 2025.
Dividend & Returns
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) has a return on equity (ROE) of -0.6%. Negative ROE indicates the company is unprofitable.
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) generated $0.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More HKPD
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates